The FTSE 100 index rose 1.2%, while the mid-cap FTSE 250 index gained 0.6%
London’s FTSE 100 rose on Tuesday after scaling a near three-month high in the previous session as the prospect of an effective COVID-19 vaccine boosted global markets, while Premier Foods tumbled after its corporate trading update.
The blue-chip FTSE 100 index was up 1.2%, with Rolls-Royce Holdings Plc surging 25.5% following a 44% jump on Monday after Pfizer announced that its coronavirus vaccine was 90% effective.
Shares of energy, insurance and auto companies were also among the biggest gainers in morning trading. The domestically focussed mid-cap FTSE 250 index added 0.6%.
The market is currently split between investors who are optimistic about the vaccine and see a way out and those who still have doubts about it, said Milan Cutkovic, market analyst at Axi.
The UK market has been underperforming because it’s suffering through Brexit and the pandemic at the same time and the pressure on Boris Johnson is greater than ever now that the economy is in a deep recession, Cutkovic said.
UK markets had started November on a strong footing, also aided by stimulus measures from the British government and the Bank of England.
Data on Tuesday, however, showed layoffs in Britain hit a record high during the third quarter, while surveys said consumer spending faded in October even as the re-introduction of lockdowns prompted a renewed stockpiling spree.
In company news, Premier Foods Plc fell 5.2% even after it raised its full-year trading profit outlook and said it expects higher demand for its brands due to the recent government restrictions on eating out.
J Sainsbury ‘s and WM Morrison Supermarkets Plc rose between 0.3% and 1.9%, while Tesco Plc dipped 0.2% after industry data showed British grocery sales increased by 9.3% in the 12 weeks to Nov. 1 as consumers in England prepared for another lockdown.
Motor insurer Direct Line Group Plc shed 3% after it posted lower premiums due to weak car sales in the face of COVID-19 crisis.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.